PEDIATRIC ONCOLOGY GROUP

儿科肿瘤组

• 批准号: 3555726
• 负责人: DONALD J FERNBACH
• 金额: $ 18.66万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 1995-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3555726
• 关键词: child (0-11); clinical trials; cooperative study; human subject; human therapy evaluation; pediatric neoplasm /cancer

The concept of the pediatric cooperative cancer group was introduced over 30 years ago, because of the rarity of pediatric malignant diseases and the vital importance of controlled trials to improve the outcome for such patients. For such a group to succeed, the collaborative contributions of individuals from a large variety of specialties and fields of research are absolutely essential. This multimodal organized approach to the treatment of childhood cancer through the cooperative group has well-demonstrated its value. The Section of Pediatric Hematology-Oncology at Baylor College of Medicine has been involved in the genesis of this kind of clinical research and has participated in the activities at every level. It is anticipated that this will continue and increase during the next grant period. Preliminary investigators are ongoing which hopefully will provide background for future Pediatric Oncology Group efforts.

引入了小儿合作癌小组的概念 30年前，由于小儿恶性疾病的稀有性和 对照试验的重要性至关重要，以改善这种结果 患者。 为了使这样一个小组成功， 来自各种专业和研究领域的个人是 绝对必要。 这种多模式有组织的治疗方法 通过合作组的儿童癌症已经很好地揭示了 价值。 贝勒学院的小儿血液肿瘤学部分 医学参与了这种临床研究的起源 并参与了各个级别的活动。 预计 在下一个赠款期间，这将继续并增加。 初步调查人员正在进行中，希望能提供 未来儿科肿瘤学小组努力的背景。